COMMUNIQUÉS West-GlobeNewswire

Shire plc : Rule 2.9 Announcement
23/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 23 May 2018 Shire [...]
Verona Pharma Files Shelf Registration Statement with SEC
23/05/2018
Shareholders’ Circular and Notice of General Meeting LONDON, May 23, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company [...]
Photocure ASA: Results for the first quarter of 2018
23/05/2018
Oslo, Norway, 23 May 2018: Photocure ASA (OSE: PHO ), today reported a revenue growth of 36% in local currency for the important U.S. market in the first quarter of 2018, contributing to Hexvix/Cysview revenues of NOK [...]
VFMCRP AND CARA THERAPEUTICS TO DEVELOP AND COMMERCIALISE CR845 INJECTION FOR CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS
23/05/2018
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) to develop and commercialise CR845/difelikefalin injection worldwide except in the US, Japan and South Korea for the treatment of chronic kidney disease-associated [...]
MyoKardia Announces Pricing of Public Offering of Common Stock
23/05/2018
SOUTH SAN FRANCISCO, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
Coherus Prices Public Offering of Common Stock
23/05/2018
REDWOOD CITY, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ) today announced the pricing of its underwritten public offering of 5,172,413 shares of its common stock at a price to the [...]
Sienna Senior Living Inc. Announces Results From Annual and Special Meeting
22/05/2018
MARKHAM, Ontario, May 22, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) is pleased to announce that it has received shareholder approval in respect of all resolutions to [...]
Insmed Announces Presentations at the American Thoracic Society 2018 International Conference
22/05/2018
Data support the benefit of treating patients with a combination of ALIS (Amikacin Liposome Inhalation Suspension) and guideline-based therapy (GBT) for the treatment of nontuberculous mycobacterial (NTM) lung disease [...]
Oncolytics Biotech® Has Applied to List its Common Shares on Nasdaq and Announces Share Consolidation
22/05/2018
CALGARY, Alberta and SAN DIEGO, May 22, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX: ONC ) (OTCQX:ONCYF), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
MyoGen: Leaders of an Anabolic Revolution
22/05/2018
GUJARAT, India, May 23, 2018 (GLOBE NEWSWIRE) -- Myogen will make you rethink what the human body is capable of. To be an athlete means to partake on a never-ending quest for self-improvement. An obsession to search for [...]
resTORbio to Host Key Opinion Leader Symposium on TORC1 Inhibition
22/05/2018
BOSTON, May 22, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]
HEALTH FOUNDATION ELECTS RYAN K. STUMPHAUZER, ESQ. TO BOARD OF DIRECTORS
22/05/2018
MIAMI,FL-, May 22, 2018 (GLOBE NEWSWIRE) -- Health Foundation of South Florida announced the election of Ryan K. Stumphauzer to its Board of Directors. The board leads the largest philanthropy dedicated to improving [...]
Mersana Therapeutics to Present Interim Phase 1 Data on XMT-1522 at the 2018 American Society of Clinical Oncology Annual Meeting
22/05/2018
Conference Call Featuring Principal Investigator Erika Hamilton, MD to be Held Monday, June 4, 2018, at 6:30 pm CDT CAMBRIDGE, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a [...]
Paratek Presents New Analysis Highlighting Efficacy of Omadacycline in Treating Community-Acquired Bacterial Pneumonia by Measures of Disease Severity
22/05/2018
Data Presented During “New Insights in Acute Pulmonary Infections” Oral Session at American Thoracic Society 2018 International Conference BOSTON, May 22, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: [...]
INSYS Therapeutics Confirms Outcome of FDA Advisory Committee Meeting on Buprenorphine Sublingual Spray
22/05/2018
PHOENIX, May 22, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, confirmed today [...]
Atrion Corporation Declares Quarterly Cash Dividend
22/05/2018
ALLEN, Texas, May 22, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI ) today announced that its Board of Directors declared a quarterly dividend of $1.20 per share on its outstanding shares of Common Stock. [...]
UBM Americas’ Pharmaceutical Executive goes ‘beyond the pages’ with new podcast
22/05/2018
Fast-paced, streaming program provides expert insights on the go ISELIN, N.J., May 22, 2018 (GLOBE NEWSWIRE) -- UBM Americas’ Pharmaceutical Executive celebrated the eighth episode of its new Pharmaceutical Executive [...]
MyDx Announces 2018 First Quarter Results
22/05/2018
MyDx Reports Positive Net Income as it Positions Itself for Growth and Investment SAN DIEGO, CA, May 22, 2018 (GLOBE NEWSWIRE) -- MyDx, Inc. ( OTC: MYDX ), a leader in science based cannabis health technologies and [...]
Ossur Hf : Transactions in relation to share buyback program
22/05/2018
Announcement no. 36/2018 Reykjavik, 22 May 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]

Pages